Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
2.
Eur J Endocrinol ; 166(5): 887-95, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22307572

RESUMO

OBJECTIVE: To study secular trends in sex hormones, anthropometry, bone measures and fractures. DESIGN: A random population sample was studied twice and subjects of similar age group were compared 13 years apart. METHODS: X-ray-verified fractures were retrieved from a random population sample of 2400 men and women (participants 1616=67%) aged 25-64 years from the WHO, MONICA Project in Gothenburg, Sweden, in 1995 and 2008. Fasting serum hormones and calcaneal ultrasound were measured in every fourth subject. In fertile women, measurements were performed on cycle day interval 7-9. RESULTS: In 2008, men had lower serum free testosterone than men of similar age in 1995 (P<0.001). Body composition, physical activity and fracture incidence were similar. In women, hormone replacement therapy (HRT) was lower in 2008, 7 vs 28% (P<0.0001), as was serum oestradiol, although use of tranquilisers and leisure time physical activity were higher. In 2008, the fracture incidence was higher in postmenopausal women, 29 vs 17% (P<0.001), and vertebral crush had increased from 8 to 19% of all fractures (P=0.031). Serum cholesterol and triglycerides were lower in all subjects in 2008 compared with that in 1995. CONCLUSIONS: Secular trends were observed with lower serum testosterone in men in 2008, but no effect was seen on the fracture incidence of these fairly young men. In postmenopausal women in 2008, there was a higher fracture incidence along with more vertebral compressions. Lower HRT use, lower serum oestradiol and higher fall risk exposure due with more tranquilisers and leisure time physical activity in 2008 may explain the results.


Assuntos
Estradiol/sangue , Fraturas Ósseas/sangue , Fraturas Ósseas/epidemiologia , Caracteres Sexuais , Testosterona/sangue , Adulto , Terapia de Reposição de Estrogênios/métodos , Feminino , Seguimentos , Humanos , Estilo de Vida , Masculino , Pessoa de Meia-Idade , Atividade Motora/fisiologia , Fumar/efeitos adversos , Fumar/metabolismo
4.
Scand J Gastroenterol ; 43(9): 1050-6, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18609169

RESUMO

OBJECTIVES: To investigate the prevalence of serological markers for chronic atrophic gastritis (AG) and Helicobacter pylori antibodies (HPAb) in an elderly population, and to examine the interrelationship and significance for cobalamin, folic acid and iron status and response to oral vitamin therapy. MATERIAL AND METHODS: The study included community-dwelling subjects (n=209), mean age 76 years, randomized to 4 month of oral daily treatment with 0.5 mg cyanocobalamin, 0.8 mg folic acid and 3 mg vitamin B(6) or placebo (double-blind). Biochemical tests were carried out before and after treatment. RESULTS: AG, as indicated by a pepsinogen I/II ratio <2.9, occurred in 14% (26/190) and HPAb in 54% (102/190) of the subjects. AG subjects had higher levels of serum methylmalonic acid (MMA) (p<0.001), plasma homocysteine (tHcy) (p<0.05), lower haemoglobin (Hb) (p<0.01) and a higher prevalence of vitamin B(12) deficiency (p<0.01). HPAb was associated with AG, whereas AG subjects without HPAb had higher tHcy and MMA levels. There was no correlation between AG and iron status. Oral vitamin treatment led to greater (albeit non-significant) improvements in MMA, tHcy and total cobalamins in AG subjects compared to non-AG subjects. CONCLUSIONS: AG is a common condition and is a significant determinant of vitamin B(12) status. AG is correlated to HPAB and lower Hb. Elderly AG subjects respond at least as well as non-AG subjects to oral treatment with B-vitamins in the doses employed.


Assuntos
Biomarcadores/sangue , Ácido Fólico/uso terapêutico , Gastrite Atrófica/tratamento farmacológico , Infecções por Helicobacter/tratamento farmacológico , Vitamina B 12/uso terapêutico , Vitamina B 6/uso terapêutico , Administração Oral , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antibacterianos/imunologia , Relação Dose-Resposta a Droga , Método Duplo-Cego , Esquema de Medicação , Feminino , Ácido Fólico/sangue , Gastrite Atrófica/sangue , Gastrite Atrófica/diagnóstico , Gastrite Atrófica/epidemiologia , Avaliação Geriátrica , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/imunologia , Helicobacter pylori/imunologia , Humanos , Ferro/sangue , Masculino , Análise Multivariada , Prevalência , Probabilidade , Valores de Referência , Análise de Regressão , Medição de Risco , Índice de Gravidade de Doença , Resultado do Tratamento , Vitamina B 12/sangue
9.
Scand J Urol Nephrol ; 39(3): 200-5, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16118090

RESUMO

OBJECTIVE: We investigated whether treatment with calcium carbonate and vitamin D3 can improve the bone mineral content of patients with ileal reservoirs for continent urinary diversion and a reduced glomerular filtration rate (GFR). MATERIAL AND METHODS: Twenty-six patients with Kock reservoirs were included in the study. Bone mineralization was determined using dual-energy X-ray absorptiometry. Kidney function was estimated from Cr-EDTA clearance and serum cystatin C concentration. Osteocalcin and parathyroid hormone in serum were also measured. Patients with reduced GFR were treated with calcium carbonate and vitamin D3 perorally. RESULTS: Bone mineral density in the femur neck and hip increased in the treatment group, as reflected by an improved T score. CONCLUSION: Patients with ileal reservoirs for continent urinary diversion and reduced kidney function should be supplemented with calcium carbonate and vitamin D3 in order to reduce the long-term risk of osteoporosis.


Assuntos
Cálcio/uso terapêutico , Colecalciferol/uso terapêutico , Bolsas Cólicas , Taxa de Filtração Glomerular , Osteoporose/prevenção & controle , Coletores de Urina , Densidade Óssea , Cistatina C , Cistatinas/sangue , Suplementos Nutricionais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
10.
Lakartidningen ; 102(10): 748, 750, 752-3, 2005.
Artigo em Sueco | MEDLINE | ID: mdl-15839166

RESUMO

Surveys of published studies on diagnostic accuracy and the performance of diagnostic tests, widely defined as any method for obtaining additional information on the health status of an individual, have revealed poor methodological quality. This holds true also for scientific journals considered to be leading in their fields. The STARD document (Standards for Reporting of Diagnostic Accuracy), which was first published in 2003, provides guidelines for the design, performance and report of such studies. Adherence to these guidelines may improve the quality of scientific publications, increased opportunities for readers to get an insight into the experimental details, improved education in medical research and increased opportunities for the disclosure of scientific fraud.


Assuntos
Viés , Ensaios Clínicos como Assunto/normas , Testes Diagnósticos de Rotina/normas , Documentação/normas , Editoração/normas , Projetos de Pesquisa/normas , Fidelidade a Diretrizes , Guias como Assunto , Humanos , Variações Dependentes do Observador , Publicações Periódicas como Assunto/normas , Controle de Qualidade
11.
Lakartidningen ; 102(5): 302-4, 306, 2005.
Artigo em Sueco | MEDLINE | ID: mdl-15754539

RESUMO

In 2003, The National Academy of Clinical Biochemistry published a consensus monograph on thyroid tests (available via Internet from 2002). The document, a result of international collaboration, describes the pathophysiological background and clinical application of the measurements as well as principles for their technical performance. Of value, and of definite clinical relevance, is the detailed description of factors affecting the results in health and disease. However, we lack a description of the sometimes large differences in values obtained with different generally available methods, as well as a presentation of the occurrence and evaluation of analytical interference and related technical factors affecting results. Readers with little experience from quantitative measurement in the clinical laboratory, therefore, are not stimulated to obtain a better understanding of causes and evaluation of unexpected results.


Assuntos
Química Clínica/normas , Laboratórios Hospitalares/normas , Doenças da Glândula Tireoide/diagnóstico , Testes de Função Tireóidea/normas , Hormônios Tireóideos/sangue , Autoanticorpos/sangue , Consenso , Humanos , Comunicação Interdisciplinar , Valores de Referência , Doenças da Glândula Tireoide/sangue , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue
12.
Lakartidningen ; 102(5): 296-8, 300-1, 2005.
Artigo em Sueco | MEDLINE | ID: mdl-15754538

RESUMO

In 1996, the Endocrinology Group in EQUALIS, in collaboration with The Thyroid Unit at The Section of Endocrinology at Sahlgrenska University Hospital, introduced a "patient-related" quality assurance program. Serum samples from patients with established or suspected thyroid disorder and/or results from thyroid-related biochemical measurements which were at variance with the clinical presentation, were analyzed by the participants of an external quality assurance program in endocrinology. The results from this program were informative as regards capacity, in the individual laboratories, for the evaluation of analytical and/or biological factors causing unexpected results from the measurement of thyroid-related serum components. We now present four clinical cases, which had offered diagnostic problems. EQUALIS, in collaboration with the participants of the external quality assurance program in endocrinology and on the basis of experiences from this program, now offers a diagnostic service for clinical chemistry laboratories and physicians when they are confronted with unexpected results from the immunochemical measurement of analytes included in the program.


Assuntos
Química Clínica/normas , Laboratórios Hospitalares/normas , Garantia da Qualidade dos Cuidados de Saúde , Doenças da Glândula Tireoide/sangue , Testes de Função Tireóidea/normas , Hormônios Tireóideos/sangue , Adolescente , Adulto , Idoso , Reações Falso-Negativas , Reações Falso-Positivas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valores de Referência , Suécia , Doenças da Glândula Tireoide/diagnóstico
14.
Eur J Haematol ; 74(2): 111-6, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15654900

RESUMO

UNLABELLED: The role of growth hormone (GH) for maintaining normal erythropoiesis among non-GH-deficient elderly subjects is not known. OBJECTIVES: To determine relationships between the concentrations of serum insulin-like growth factor-1 (IGF-1) and it's carrier protein insulin-like growth factor binding protein 3 (IGFBP-3), as well as plasma erythropoietin (EPO), and blood haemoglobin (Hb) in elderly subjects. METHODS: Serum IGF-1 and IGFBP-3 and plasma EPO were, in addition to basal haematological tests, measured in a community based representative population sample of 70-yr-olds (n = 619; 317 women and 302 men). Statistical analyses were made before and after exclusion of non-healthy subjects. RESULTS: Mean IGF-1 concentration was higher among men than women (155 vs. 138 mug/L, P = 0.0000), and that of IGFBP3 lower (2.21 vs. 2.65 mg/L, P = 0.0000). Exclusion of subjects with demonstrable disorders did not significantly influence the distributions of serum-IGF-1 and serum-BP-3. Hb concentration was positively correlated to concentrations of IGF-1 (r = 0.15, P < 0.01 for the men; r = 0.34, P < 0.001 for the women), and IGFBP-3 (r = 0.07, n.s. for the men; r = 0.27, P < 0.001 for the women), and negatively correlated to EPO concentration (r = -0.34, P < 0.001 for the men; r = -0.42, P < 0.001 for the women). In multivariate analysis, serum concentrations of IGF-1, iron, and plasma concentrations of EPO were independently correlated to Hb among both men and women. CONCLUSION: GH and/or IGF-1 are, independently from EPO and regardless of health status and sex, a significant determinant of Hb in elderly subjects.


Assuntos
Eritropoese/fisiologia , Hemoglobinas/análise , Fator de Crescimento Insulin-Like I/análise , Idoso , Biomarcadores/sangue , Eritropoetina/sangue , Feminino , Hormônio do Crescimento/sangue , Humanos , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Masculino , Valor Preditivo dos Testes , Fatores Sexuais
16.
Scand J Prim Health Care ; 22(3): 187-90, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15370797

RESUMO

OBJECTIVE: To investigate plasma brain natriuretic peptide (p-BNP) in consecutive primary care patients for heart failure screening. DESIGN: Open, descriptive. SETTING: Three primary care clinics, university hospital. SUBJECTS: 291 consecutive patients, > or =40 years. MAIN OUTCOME MEASURES: p-BNP and general practitioners estimated probability of CHF. RESULTS: Median p-BNP was 29 ng/L. In 42% p-BNP was >40 ng/L in the first sample. In 41 patients further investigated, median p-BNP was 98 ng/L, with a correlation between p-BNP and physicians' estimation of probability of heart failure (r=0.469, p<0.0001). New York Heart Association class was correlated to p-BNP (r=0.343, p=0.034). No correlation between ejection fraction and p-BNP was seen. CONCLUSION: P-BNP concentrations in unselected primary care patients of 40 years of age or above were elevated in a larger proportion of patients than previously reported. Owing to the low specificity, p-BNP concentration limits have to be defined before the test can be used for screening in primary care.


Assuntos
Fator Natriurético Atrial , Biomarcadores/sangue , Medicina de Família e Comunidade/métodos , Insuficiência Cardíaca/diagnóstico , Programas de Rastreamento/métodos , Peptídeo Natriurético Encefálico , Idoso , Fator Natriurético Atrial/sangue , Feminino , Insuficiência Cardíaca/epidemiologia , Insuficiência Cardíaca/prevenção & controle , Hospitais Universitários , Humanos , Masculino , Peptídeo Natriurético Encefálico/sangue , Ambulatório Hospitalar , Valor Preditivo dos Testes , Prognóstico , Sensibilidade e Especificidade , Suécia
19.
Hepatogastroenterology ; 50(53): 1415-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14571751

RESUMO

BACKGROUND/AIMS: Malabsorption has long been recognized as a cause of osteopenia, and mild forms of osteopenia are present in many gastrointestinal disorders. The aim of this study was to determine if osteopenia is common in patients with small intestinal bacterial overgrowth. METHODOLOGY: Bone mineral density was measured in fourteen patients with small intestinal bacterial overgrowth. Patients with obvious structural predisposing conditions such as previous gastric operations, small bowel strictures and small bowel diverticula, were excluded. Measurements were made in the distal right radius and ulna, in the hip and in the spine. The results were compared to those of a reference population. Radiographs of the spine were assessed for evidence of vertebral fractures. Blood samples were analyzed for serum concentrations of 25-hydroxyvitamin-D3 and 1,25-dihydroxyvitamin-D3, alkaline phosphatase activity, ionized calcium, intact parathyroid hormone and osteocalcin. All patients completed a questionnaire concerning, inter alia, previous fractures, past and current diseases, tobacco smoking and medication. RESULTS: Patients with small intestinal bacterial overgrowth had significantly low bone density in the femoral neck (p < 0.01) and in the lumbar spine (p < 0.05), compared to a reference population. Six of 14 (43%) patients had had fractures. CONCLUSIONS: Patients with small intestinal bacterial overgrowth have low bone mineral density. In patients with osteopenia of unknown origin, small intestinal bacterial overgrowth should be considered.


Assuntos
Doenças Ósseas Metabólicas/fisiopatologia , Intestino Delgado/microbiologia , Idoso , Densidade Óssea , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
20.
Cardiol Young ; 13(3): 268-74, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12903875

RESUMO

We evaluated the concentrations of the brain and atrial natriuretic peptides in the plasma as markers of ventricular function and volume load in children with functionally univentricular hearts. We studied 7 children aged from 0.5 to 0.7 years with functionally univentricular hearts who had undergone a first palliative operation, and 10 children aged from 1.8 to 3.7 years who had undergone a bidirectional Glenn anastomosis at ages ranging from 0.4 to 1.0 year. As a control group, we studied 14 children without heart defects aged from 0.1 to 4.5 years. Levels of the brain natriuretic peptide were measured at 8.3 to 122 ng/l, with a mean of 52.8 ng/l, after the first palliative operation, compared to 0 to 16 ng/l, with a mean of 7.3 ng/l, after a bidirectional Glenn anastomosis, and 0 to 13.8 ng/l, with a mean of 5.9 ng/l, in the children serving as controls. Corresponding values for atrial natriuretic peptide were 17 to 203 ng/l, with a mean of 103 ng/l, after the first palliative operation, compared to 16 to 54 ng/l, with a mean of 29 ng/l, after the bidirectional Glenn anastomosis, and 12 to 52 ng/l, with a mean of 32 ng/l in the controls. Echocardiography showed that all the children with functionally univentricular hearts had normal ventricular function. Blood presssure, pulmonary arterial pressure, and arterial saturations of oxygen did not differ between the groups. We conclude, that in children with functionally univentricular hearts, the volume overload imposed on the heart after the first palliative operation is associated with increased production of brain and atrial natriuretic peptides, while after ventricular unloading, levels of the natriuretic peptides return to control values.


Assuntos
Fator Natriurético Atrial/sangue , Procedimentos Cirúrgicos Cardíacos , Ventrículos do Coração/anormalidades , Peptídeo Natriurético Encefálico/sangue , Pressão Sanguínea , Humanos , Ensaio Imunorradiométrico , Lactente , Oxigênio/sangue , Cuidados Paliativos , Período Pós-Operatório , Artéria Pulmonar/fisiopatologia , Função Ventricular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA